Hasil Pencarian - Sandra Rutzner
- Menampilkan 1 - 9 hasil dari 9
-
1
-
2
-
3
Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhib... oleh Jian-Guo Zhou, Benjamin Frey, Hu Ma, Markus Hecht, Sandra Rutzner, Ina Becker, Rainer Fietkau, Udo Gaipl, Anna-Jasmina Donaubauer, Philipp Schubert, Claudia Schweizer
Diterbitkan 2021-02-01Dapatkan teks lengkap
Artikel -
4
Predictive Value of Multiparametric MRI for Response to Single-Cycle Induction Chemo-Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma oleh Konstantin Hellwig, Stephan Ellmann, Markus Eckstein, Marco Wiesmueller, Sandra Rutzner, Sandra Rutzner, Sabine Semrau, Sabine Semrau, Benjamin Frey, Benjamin Frey, Udo S. Gaipl, Udo S. Gaipl, Antoniu Oreste Gostian, Antoniu Oreste Gostian, Arndt Hartmann, Arndt Hartmann, Heinrich Iro, Heinrich Iro, Rainer Fietkau, Rainer Fietkau, Michael Uder, Michael Uder, Markus Hecht, Markus Hecht, Tobias Bäuerle, Tobias Bäuerle
Diterbitkan 2021-10-01Dapatkan teks lengkap
Artikel -
5
Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors oleh Philipp Schubert, Philipp Schubert, Sandra Rutzner, Sandra Rutzner, Markus Eckstein, Markus Eckstein, Benjamin Frey, Benjamin Frey, Claudia Schweizer, Claudia Schweizer, Marlen Haderlein, Marlen Haderlein, Sebastian Lettmaier, Sebastian Lettmaier, Sabine Semrau, Sabine Semrau, Antoniu-Oreste Gostian, Antoniu-Oreste Gostian, Jian-Guo Zhou, Jian-Guo Zhou, Jian-Guo Zhou, Udo S. Gaipl, Udo S. Gaipl, Rainer Fietkau, Rainer Fietkau, Markus Hecht, Markus Hecht
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
6
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors oleh Luisa Maria Griewing, Claudia Schweizer, Philipp Schubert, Sandra Rutzner, Markus Eckstein, Benjamin Frey, Marlen Haderlein, Thomas Weissmann, Sabine Semrau, Antoniu-Oreste Gostian, Sarina K. Müller, Maximilian Traxdorf, Heinrich Iro, Jian-Guo Zhou, Udo S. Gaipl, Rainer Fietkau, Markus Hecht
Diterbitkan 2021-03-01Dapatkan teks lengkap
Artikel -
7
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8 oleh Carol I Geppert, Arndt Hartmann, Benjamin Frey, Markus Eckstein, Markus Hecht, Antoniu Oreste Gostian, Sandra Rutzner, Jens von der Grün, Thomas Illmer, Matthias G Hautmann, Gunther Klautke, Simon Laban, Thomas Brunner, Axel Hinke, Ina Becker, Sabine Semrau, Panagiotis Balermpas, Wilfried Budach, Heinrich Iro, Rainer Fietkau
Diterbitkan 2020-07-01Dapatkan teks lengkap
Artikel -
8
Improving the therapeutic index in adoptive cell therapy: key factors that impact efficacy oleh Carol I Geppert, Arndt Hartmann, Benjamin Frey, Markus Eckstein, Markus Hecht, Antoniu Oreste Gostian, Sandra Rutzner, Jens von der Grün, Thomas Illmer, Matthias G Hautmann, Gunther Klautke, Simon Laban, Thomas Brunner, Axel Hinke, Ina Becker, Sabine Semrau, Panagiotis Balermpas, Wilfried Budach, Heinrich Iro, Rainer Fietkau
Diterbitkan 2020-07-01Dapatkan teks lengkap
Artikel -
9
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer oleh Udo S Gaipl, Arndt Hartmann, Jian-Guo Zhou, Benjamin Frey, Markus Eckstein, Markus Hecht, Sandra Rutzner, Jens von der Grün, Thomas Illmer, Matthias G Hautmann, Gunther Klautke, Simon Laban, Axel Hinke, Ina Becker, Sabine Semrau, Panagiotis Balermpas, Wilfried Budach, Heinrich Iro, Rainer Fietkau, Anna-Jasmina Donaubauer, Thomas B Brunner, Bálint Tamaskovics, Antoniu-Oreste Gostian
Diterbitkan 2022-01-01Dapatkan teks lengkap
Artikel